OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nanobodies as powerful pulmonary targeted biotherapeutics against SARS-CoV-2, pharmaceutical point of view
Ali Najmeddin, Mina Bahrololoumi Shapourabadi, Mahdi Behdani, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2021) Vol. 1865, Iss. 11, pp. 129974-129974
Open Access | Times Cited: 15
Ali Najmeddin, Mina Bahrololoumi Shapourabadi, Mahdi Behdani, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2021) Vol. 1865, Iss. 11, pp. 129974-129974
Open Access | Times Cited: 15
Showing 15 citing articles:
Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy
Mehregan Babamohamadi, Nastaran Keshavarz Mohammadi, Elham Faryadi, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 28
Mehregan Babamohamadi, Nastaran Keshavarz Mohammadi, Elham Faryadi, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 28
NanoLAS: a comprehensive nanobody database with data integration, consolidation and application
Shuchang Xiong, Zhengwen Liu, Xin Yi, et al.
Database (2024) Vol. 2024
Open Access | Times Cited: 8
Shuchang Xiong, Zhengwen Liu, Xin Yi, et al.
Database (2024) Vol. 2024
Open Access | Times Cited: 8
Immunomodulatory approaches in managing lung inflammation in COVID‐19: A double‐edge sword
Geetika Verma, Manish Dhawan, AbdulRahman A. Saied, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 9
Open Access | Times Cited: 18
Geetika Verma, Manish Dhawan, AbdulRahman A. Saied, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 9
Open Access | Times Cited: 18
Bovine-derived antibodies and camelid-derived nanobodies as biotherapeutic weapons against SARS-CoV-2 and its variants: A review article
AbdulRahman A. Saied, Asmaa A. Metwally, Moses Alobo, et al.
International Journal of Surgery (2022) Vol. 98, pp. 106233-106233
Open Access | Times Cited: 23
AbdulRahman A. Saied, Asmaa A. Metwally, Moses Alobo, et al.
International Journal of Surgery (2022) Vol. 98, pp. 106233-106233
Open Access | Times Cited: 23
Immunovirotherapy: The role of antibody based therapeutics combination with oncolytic viruses
Mahdie Jafari, Maryam Kadkhodazadeh, Mina Bahrololoumi Shapourabadi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Mahdie Jafari, Maryam Kadkhodazadeh, Mina Bahrololoumi Shapourabadi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Emerging Landscape of Nanobodies and Their Neutralizing Applications against SARS-CoV-2 Virus
Xuemei Feng, Hu Wang
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 7, pp. 925-942
Open Access | Times Cited: 10
Xuemei Feng, Hu Wang
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 7, pp. 925-942
Open Access | Times Cited: 10
COVID‐19 cooling: Nanostrategies targeting cytokine storm for controlling severe and critical symptoms
Yu Zheng, Yuke Li, Li Mao, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 2, pp. 738-811
Closed Access | Times Cited: 8
Yu Zheng, Yuke Li, Li Mao, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 2, pp. 738-811
Closed Access | Times Cited: 8
The role of single-domain antibodies (or nanobodies) in SARS-CoV-2 neutralization
Arghavan Zebardast, Parastoo Hosseini, Ali Hasanzadeh, et al.
Molecular Biology Reports (2021) Vol. 49, Iss. 1, pp. 647-656
Open Access | Times Cited: 13
Arghavan Zebardast, Parastoo Hosseini, Ali Hasanzadeh, et al.
Molecular Biology Reports (2021) Vol. 49, Iss. 1, pp. 647-656
Open Access | Times Cited: 13
Applications of nanobodies in the prevention, detection, and treatment of the evolving SARS-CoV-2
Wenyi Wang, Yue Hu, Bohan Li, et al.
Biochemical Pharmacology (2022) Vol. 208, pp. 115401-115401
Open Access | Times Cited: 8
Wenyi Wang, Yue Hu, Bohan Li, et al.
Biochemical Pharmacology (2022) Vol. 208, pp. 115401-115401
Open Access | Times Cited: 8
Optimized silk fibroin nanoparticle functionalization with anti-CEA nanobody enhancing active targeting of colorectal cancer cells
Xiying Fan, Xinying Peng, Tingting Wang, et al.
Biomedical Materials (2023) Vol. 18, Iss. 4, pp. 045027-045027
Closed Access | Times Cited: 2
Xiying Fan, Xinying Peng, Tingting Wang, et al.
Biomedical Materials (2023) Vol. 18, Iss. 4, pp. 045027-045027
Closed Access | Times Cited: 2
NanoLAS: a Comprehensive Nanobody Database with Data Integration, Consolidation, and Application
Shuchang Xiong, Zhengwen Liu, Xin Yi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Shuchang Xiong, Zhengwen Liu, Xin Yi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Nanobodies as Spray and Aerosol Particles: A Breakthrough in Treating Respiratory Viral Infections
Mujahed I. Mustafa, Ahmed Mohammed
(2023)
Open Access | Times Cited: 2
Mujahed I. Mustafa, Ahmed Mohammed
(2023)
Open Access | Times Cited: 2
NanoLAS 2.0: A Comprehensive Update on a Nanobody-Focused Platform with Advanced Visualization and Docking Simulation Features
Zebiao Zheng, Wei Qin, Kangrui Yu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Zebiao Zheng, Wei Qin, Kangrui Yu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Antibody Therapy for COVID-19: Categories, Pros, and Cons
Hadi Zare Marzouni, Marjan Rahbar, Nazanin Sadat Seddighi, et al.
Viral Immunology (2022) Vol. 35, Iss. 8, pp. 517-528
Closed Access | Times Cited: 1
Hadi Zare Marzouni, Marjan Rahbar, Nazanin Sadat Seddighi, et al.
Viral Immunology (2022) Vol. 35, Iss. 8, pp. 517-528
Closed Access | Times Cited: 1
Recombinant Antibodies to Face SARS-CoV-2 Syndemic
Maykel González‐Torres, Gerardo Leyva‐Gómez, María Luisa Del Prado-Audelo, et al.
Cellular and Molecular Biology (2023) Vol. 69, Iss. 7, pp. 24-27
Open Access
Maykel González‐Torres, Gerardo Leyva‐Gómez, María Luisa Del Prado-Audelo, et al.
Cellular and Molecular Biology (2023) Vol. 69, Iss. 7, pp. 24-27
Open Access
